FinTechFunding

Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Previous article
MRG Metals: Completes phase two drilling in Mozambique
Next article
PainChek: Signs partnership deal with disability service provider
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

FCA Announces Second Cohort for AI Live Testing Initiative

New phase aims to improve integration of AI in financial services.Highlights: FCA launches second cohort for AI live...
FinTech

Cab Payments Strengthens Case Against Helios Blocking Takeover Bid

Cab Payments contests Helios Investment's actions regarding merger talks.Highlights: Cab Payments accuses Helios of blocking a crucial takeover...
FinTech

Ex-Stripe Team Secures $75 Million to Boost Operations Platform

Funding aims to enhance operations for businesses in various sectors.Highlights: Ex-Stripe founders raise $75 million for operations platform.The...
FinTech

Government Advances Reforms to Secure UK Payments Sector

New initiatives aim to enhance the resilience and efficiency of the payments landscape.Highlights: UK government proposes new reforms...